Acupuncture for the Treatment of Post-Traumatic Stress Disorder (PTSD)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate acupuncture as a treatment for Post-Traumatic Stress Disorder (PTSD) and to correlate the diagnosis of PTSD with Traditional Chinese Medicine (TCM) diagnostic patterns.
| Condition | Intervention |
|---|---|
|
Stress Disorders, Post-Traumatic |
Procedure: Acupuncture Behavioral: Cognitive Behavioral Therapy |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind Primary Purpose: Treatment |
| Official Title: | Acupuncture Diagnosis and Treatment of DSM-IV PTSD |
| Estimated Enrollment: | 90 |
| Study Start Date: | September 2002 |
| Estimated Study Completion Date: | May 2004 |
This study will evaluate: 1) the TCM diagnostic differentiation patterns of people who have PTSD as defined by the Diagnostic and Statistical Manual, 4th edition; 2) if an acupuncture treatment approach is acceptable to people with PTSD; and 3) if an acupuncture treatment approach is associated with a reduction in PTSD symptoms that is comparable to that of standard treatments. Because symptoms of depression, insomnia, and pain are often associated with PTSD, we will also evaluate the potential benefit of an acupuncture approach to depression, insomnia, and pain symptoms in people with PTSD.
Patients in this study will be randomized to one of three groups. Group A will receive acupuncture therapy. Group B will receive standard Cognitive Behavior Therapy. Group C is a control group and will receive no treatment. Patients in Groups A and B will undergo a total of 24 hours of therapy over the 3 month study course. All patients will have five nontherapeutic study visits; these visits will address diagnosis and assessment. Study visits will include assessments of PTSD symptoms, sleep symptoms, and level of impairment.
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria
- DSM-IV diagnosis of PTSD
- Stage I PTSD symptoms
- PTSD Symptom Scale-Self Report (PSS-SR) score > 16
- Meets PSS-SR diagnostic criteria
Exclusion Criteria
- Stage I substance abuse and/or dependence in the past 6 months
- Psychotic disorder
- Inability to commit to treatment or wait-list conditions
- Current treatment specifically for PTSD
- Certain medical conditions, including thyroid disease, class IV heart failure, active cancer treatment, and uncontrolled diabetes
- Pregnant
- Use of benzodiazepines, narcotics, opiates, narcotic antagonists, sleep medication, muscle relaxants, analgesics, or sedatives.
Contacts and Locations More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00055354 History of Changes |
| Other Study ID Numbers: | R21 AT001229-01 |
| Study First Received: | February 26, 2003 |
| Last Updated: | August 17, 2006 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):
|
Acupuncture Medicine, Chinese Traditional |
Additional relevant MeSH terms:
|
Stress Disorders, Post-Traumatic Stress Disorders, Traumatic Anxiety Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 22, 2013